{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:56:58Z","timestamp":1785499018884,"version":"3.56.0"},"reference-count":66,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2025.2536420","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T08:17:56Z","timestamp":1753172276000},"page":"1198-1213","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland"],"prefix":"10.1080","volume":"28","author":[{"given":"Aude","family":"Ambresin","sequence":"first","affiliation":[{"name":"Swiss Visio Retina Research Center, Swiss Visio Montchoisi","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3871-4239","authenticated-orcid":false,"given":"S.W.","family":"Quist","sequence":"additional","affiliation":[{"name":"University Medical Center Groningen","place":["Groningen, The Netherlands"]},{"name":"Asc Academics","place":["Groningen, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boer","sequence":"additional","affiliation":[{"name":"Asc Academics","place":["Groningen, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Maamari","sequence":"additional","affiliation":[{"name":"Bayer (Schweiz) AG","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Barthelmes","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital and University of Zurich","place":["Zurich, Switzerland"]},{"name":"Save Sight Institute, The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30489-7"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314422"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S67536"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30052-3"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01211.x"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000458539"},{"key":"e_1_3_4_8_1","unstructured":"Diabetes: World Health Organization. 2024 [cited 2025 Jan 7]. Available from: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/diabetes"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.01.009"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305702"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00063-1"},{"key":"e_1_3_4_12_1","author":"Wolf S.","year":"2010","unstructured":"Wolf S. Statement of the swiss vitreo retinal group on current therapeutic options in neovascular age-related macular degeneration. 2010. Available from: https:\/\/augenklinik-bern.ch\/wp-content\/uploads\/2019\/09\/SVRG-Statement_0204_UNo.pdf","journal-title":"Statement of the swiss vitreo retinal group on current therapeutic options in neovascular age-related macular degeneration"},{"key":"e_1_3_4_13_1","author":"(SVRG) S","year":"2012","unstructured":"(SVRG) S. Stellungnahme Der Swiss Vitreo Retina Group (SVRG) Zur CATT-Studie. 2012.","journal-title":"Stellungnahme Der Swiss Vitreo Retina Group (SVRG) Zur CATT-Studie"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.017"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2023.5248"},{"key":"e_1_3_4_16_1","unstructured":"Public Summary SwissPAR dated 17.08.2022. Vabysmo\u00ae (active substance: faricimab). 2022. Available from: https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/about-us\/publications\/public-summary-swiss-par\/public-summary-swiss-par-vabysmo.html"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00018-6"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00010-1"},{"key":"e_1_3_4_19_1","unstructured":"Two-year Results for Aflibercept 8\u2009mg from Pivotal PHOTON Trial Demonstrate Durable Vision Gains at Extended Dosing Intervals in Diabetic Macular Edema. Regeneron. 2023 [cited 2024 Dec 1]. Available from: https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/two-year-results-aflibercept-8-mg-pivotal-photon-trial\/"},{"key":"e_1_3_4_20_1","unstructured":"Three-year Results for EYLEA HD\u00ae (aflibercept) Injection 8\u2009mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema. Regeneron. 2024 [cited 2024 Dec 1]. Available from: https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/three-year-results-eylea-hdr-aflibercept-injection-8-mg\/"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S409103"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2022-001188"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.4401"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.1150"},{"key":"e_1_3_4_25_1","unstructured":"Healthcare expenditure rises to over CHF 100 billion: KOF Swiss Economic Institute. 2024 [cited 2025 Jan 9]. Available from: https:\/\/kof.ethz.ch\/en\/news-and-events\/media\/press-releases\/2024\/11\/health-expanditures-forecast.html#:\u223c:text=Per%2Dcapita%20annual%20healthcare%20expenditure and%20CHF%2011%2C594%20for%202026"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-10124-3"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S80536"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.07.010"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-024-06588-6"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197670"},{"key":"e_1_3_4_31_1","unstructured":"EYLEA Inj L\u00f6s 8\u2009mg\/0.07ml Durchstfl Refdata [cited 2024 Jun 26]. Available from: https:\/\/sai.refdata.ch\/detail\/61326"},{"key":"e_1_3_4_32_1","unstructured":"EYLEA Inj L\u00f6s 2\u2009mg\/0.05ml Durchstfl: Refdata [cited 2024 Jun 26]. Available from: https:\/\/sai.refdata.ch\/detail\/9048"},{"key":"e_1_3_4_33_1","unstructured":"Vabysmo. Refdata. [cited 2024 Jun 26]. Available from: https:\/\/swissmedicinfo.ch\/showText.aspx?textType=FI&lang=EN&authNr=68395&supportMultipleResults=1"},{"key":"e_1_3_4_34_1","unstructured":"BYOOVIZ 2.3\u2009mg\/0.23ml m Filterna Durchstf 0.23\u2009ml: Refdata. [cited 2024 Jun 26]. Available from: https:\/\/sai.refdata.ch\/detail\/59002"},{"key":"e_1_3_4_35_1","unstructured":"LUCENTIS 2.3\u2009mg\/0.23ml m Zubeh\u00f6r Durchstf 0.23\u2009ml: Refdata. [cited 2024 Jun 26]. Available from: https:\/\/sai.refdata.ch\/detail\/24402"},{"key":"e_1_3_4_36_1","unstructured":"RANIVISIO Inj L\u00f6s 2.3\u2009mg\/0.23ml Durchstf 0.23\u2009ml: Refdata. [cited 2024 Jun 26]. Available from: https:\/\/sai.refdata.ch\/detail\/60821"},{"key":"e_1_3_4_37_1","unstructured":"XIMLUCI 2.3\u2009mg\/0.23ml m Filterna Durchstf 0.23\u2009ml: Refdata. [cited 2024 Jun 26]. Available from: https:\/\/sai.refdata.ch\/detail\/61962"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2023.06.009"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S269162"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.797108"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007419.pub6"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02577-1"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76354-1"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.08.009"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.07.014"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83811-y"},{"key":"e_1_3_4_47_1","unstructured":"Two-year PULSAR Trial Results for Aflibercept 8\u2009mg Demonstrate Durable Vision Gains at Extended Dosing Intervals in Wet Age-related Macular Degeneration. Regeneron; 2023 [cited 2024 Dec 1]. Available from: https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/two-year-pulsar-trial-results-aflibercept-8-mg-demonstrate\/"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01236-x"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003128"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.01.013"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.5540"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.07.041"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.09.018"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.12.026"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.02.005"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000504753"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78954-3"},{"key":"e_1_3_4_58_1","unstructured":"Aflibercept - Medication price: Schweizerische Eidgenossenschaft. [cited 2024 Dec 1]. Available from: https:\/\/www.xn\u2013spezialittenliste-yqb.ch\/ShowPreparations.aspx?searchType=Substance&searchValue=Afliberceptum"},{"key":"e_1_3_4_59_1","unstructured":"Faricimab - Medication price: Schweizerische Eidgenossenschaft. [cited 2024 Dec 1]. Available from: https:\/\/www.spezialitaetenliste.ch\/ShowPreparations.aspx?searchType=SwissMedicNr&searchValue=68395001"},{"key":"e_1_3_4_60_1","unstructured":"Ranibizumab - Medication price: Schweizerische Eidgenossenschaft. [cited 2024 Dec 1]. Available from: https:\/\/www.spezialitaetenliste.ch\/ShowPreparations.aspx?searchType=ATCCODE&searchValue=S01LA04"},{"issue":"7","key":"e_1_3_4_61_1","first-page":"3154","article-title":"Population pharmacokinetic modeling and simulation of ocular clearance for aflibercept 8\u2009mg and 2\u2009mg and association with durability of effect","volume":"65","author":"Kaiser PK","year":"2024","unstructured":"Kaiser PK, Turner KC, Bihorel S, et\u00a0al. Population pharmacokinetic modeling and simulation of ocular clearance for aflibercept 8\u2009mg and 2\u2009mg and association with durability of effect. Investig Ophthalmol Visual Sci. 2024;65(7):3154\u20133154.","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"4","key":"e_1_3_4_62_1","first-page":"1","article-title":"Sturney. Switzerland Health system review","volume":"17","author":"De Pietro C","year":"2015","unstructured":"De Pietro C, Camenzind P, Sturny I, et\u00a0al. Sturney. Switzerland Health system review. Health Syst Transit. 2015;17(4):1\u2013288, xix.","journal-title":"Health Syst Transit"},{"key":"e_1_3_4_63_1","unstructured":"Ageing in Switzerland: Bundesamt f\u00fcr Statistik. [cited 2025 Jan 8]. Available from: https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/cross-sectional-topics\/ageing-switzerland.html"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05187-z"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.06.005"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14712"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14929"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2536420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:47:15Z","timestamp":1766400435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2536420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2536420"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2536420","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}